(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate

C150H258N24O31S2 — CID 158017281

About (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate

(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate (PubChem CID 158017281) has the molecular formula C150H258N24O31S2 and a molecular weight of 2957.98 g/mol. Its IUPAC name is (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate.

Molecular Properties

• Compound Name: (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate
• PubChem CID: 158017281
• Molecular Formula: C150H258N24O31S2
• Molecular Weight: 2957.98 g/mol
• Exact Mass: 2955.88
• IUPAC Name: (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate
• SMILES: CC[C@@H]1NC(=O)[C@@H]2[C@@H]([C@H](C)CCCCCOS(C)(=O)=O)ON2C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)CC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)CC(=O)[C@H]([C@@H](C)OCCCCN2CCOCC2)N(C)C(=O)[C@@H](C)N(C)C1=O.CC[C@@H]1NC(=O)[C@@H]2[C@@H]([C@H](C)CCCCCSc3nnnn3-c3ccccc3)ON2C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)CC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)CC(=O)[C@H]([C@@H](C)OCCCCN2CCOCC2)N(C)C(=O)[C@@H](C)N(C)C1=O
• InChI: InChI=1S/C78H130N14O14S.C72H128N10O17S/c1-23-59-74(100)84(17)55(15)72(98)89(22)66(56(16)105-38-30-29-35-90-36-39-104-40-37-90)64(94)46-58(50(8)9)73(99)85(18)60(42-47(2)3)63(93)45-53(13)69(95)79-54(14)71(97)86(19)61(43-48(4)5)75(101)87(20)62(44-49(6)7)76(102)88(21)65(51(10)11)77(103)92-67(70(96)80-59)68(106-92)52(12)32-26-25-31-41-107-78-81-82-83-91(78)57-33-27-24-28-34-57;1-24-54-69(90)75(17)51(15)67(88)80(22)61(52(16)97-34-29-27-31-81-32-36-96-37-33-81)59(84)42-53(46(8)9)68(89)76(18)55(38-43(2)3)58(83)41-49(13)64(85)73-50(14)66(87)77(19)56(39-44(4)5)70(91)78(20)57(40-45(6)7)71(92)79(21)60(47(10)11)72(93)82-62(65(86)74-54)63(99-82)48(12)30-26-25-28-35-98-100(23,94)95/h24,27-28,33-34,47-56,58-62,65-68H,23,25-26,29-32,35-46H2,1-22H3,(H,79,95)(H,80,96);43-57,60-63H,24-42H2,1-23H3,(H,73,85)(H,74,86)/t52-,53-,54-,55-,56-,58+,59+,60+,61+,62+,65+,66+,67+,68-;48-,49-,50-,51-,52-,53+,54+,55+,56+,57+,60+,61+,62+,63-/m11/s1
• InChIKey: FFPYWGIAGUGDSB-XOGUCKMJSA-N
• XLogP: 12.20
• TPSA: 617.85 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 38
• Rotatable Bonds: 49
• Heavy Atoms: 207
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2957.98
LogP ≤ 5	12.20
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	38

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate?

The IUPAC name of (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate (CID 158017281) is (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate.

What is the SMILES notation for (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate?

The canonical SMILES for (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate is CC[C@@H]1NC(=O)[C@@H]2[C@@H]([C@H](C)CCCCCOS(C)(=O)=O)ON2C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)CC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)CC(=O)[C@H]([C@@H](C)OCCCCN2CCOCC2)N(C)C(=O)[C@@H](C)N(C)C1=O.CC[C@@H]1NC(=O)[C@@H]2[C@@H]([C@H](C)CCCCCSc3nnnn3-c3ccccc3)ON2C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)CC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)CC(=O)[C@H]([C@@H](C)OCCCCN2CCOCC2)N(C)C(=O)[C@@H](C)N(C)C1=O.

What is the InChIKey of (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate?

The InChIKey is FFPYWGIAGUGDSB-XOGUCKMJSA-N. The full InChI is InChI=1S/C78H130N14O14S.C72H128N10O17S/c1-23-59-74(100)84(17)55(15)72(98)89(22)66(56(16)105-38-30-29-35-90-36-39-104-40-37-90)64(94)46-58(50(8)9)73(99)85(18)60(42-47(2)3)63(93)45-53(13)69(95)79-54(14)71(97)86(19)61(43-48(4)5)75(101)87(20)62(44-49(6)7)76(102)88(21)65(51(10)11)77(103)92-67(70(96)80-59)68(106-92)52(12)32-26-25-31-41-107-78-81-82-83-91(78)57-33-27-24-28-34-57;1-24-54-69(90)75(17)51(15)67(88)80(22)61(52(16)97-34-29-27-31-81-32-36-96-37-33-81)59(84)42-53(46(8)9)68(89)76(18)55(38-43(2)3)58(83)41-49(13)64(85)73-50(14)66(87)77(19)56(39-44(4)5)70(91)78(20)57(40-45(6)7)71(92)79(21)60(47(10)11)72(93)82-62(65(86)74-54)63(99-82)48(12)30-26-25-28-35-98-100(23,94)95/h24,27-28,33-34,47-56,58-62,65-68H,23,25-26,29-32,35-46H2,1-22H3,(H,79,95)(H,80,96);43-57,60-63H,24-42H2,1-23H3,(H,73,85)(H,74,86)/t52-,53-,54-,55-,56-,58+,59+,60+,61+,62+,65+,66+,67+,68-;48-,49-,50-,51-,52-,53+,54+,55+,56+,57+,60+,61+,62+,63-/m11/s1.

What are the key properties of (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate?

(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate has a molecular weight of 2957.98 g/mol, XLogP of 12.20, 49 rotatable bonds, 4 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for (3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-34-[(2R)-7-(1-phenyltetrazol-5-yl)sulfanylheptan-2-yl]-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;[(6R)-6-[(3S,6S,9S,12R,15R,18S,21S,24S,27R,30S,33S,34R)-30-ethyl-4,7,10,12,15,19,25,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-24-[(1R)-1-(4-morpholin-4-ylbutoxy)ethyl]-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-35-oxa-1,4,7,10,13,19,25,28,31-nonazabicyclo[31.2.0]pentatriacontan-34-yl]heptyl] methanesulfonate is sourced from PubChem (CID 158017281), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).